The multipartner, multidisciplinary project OLIGOMED addresses urgent needs in healthcare, in particular cancer, Huntington's Disease and cardiovascular diseases.

​

We apply cutting edge oligonucleotide technology to find innovative solutions and create a novel platform for personalised medicine.

 

Click below to learn more about our rationale behind the project, to meet the team, to learn more about the consortium, and to keep up to date with us.